International Board of Advisory Directors


Antonio Toniolo, M.D., FAMH
Professor of Medical Microbiology, University of Insubria Medical School, Varese, Italy.
Dr. Antonio Toniolo is ad Honorem Professor at the International School of Medical Sciences, Panama City, Panama.
He is Professor of Medical Microbiology and Director of the Clinical Microbiology Laboratory at the University of Insubria Medical Center in Varese, Italy. Graduated in Medicine at the University of Pisa, Italy in 1972, obtained his board certification in Medical Microbiology in 1976. He then became Assistant and Associate Professor at the same Medical School.
After 3-year research training at the National Institutes of Health (Bethesda, Maryland) under Abner Louis Notkins, he served as Professor of Medical Microbiology with clinical responsibilities at four different Italian Medical Schools: Sassari, Pisa, Pavia, Insubria (1998-present). Visiting Professor of Virology, University of Tokyo (1997).
President of the Italian Society for Medical and Clinical Microbiology (2001-2006), he is member of the American Society for Microbiology (ASM), the NIH Alumni Association (NIHAA), the International Society for Pediatric and Adolescent Diabetes (ISPAD), the Steering Committee of Virus in Diabetes International Study Group (VIDIS), the European Polio Union (EPU).
Since 2013 he is Senior Research Scholar at “Centro Beniamino Segre”, Accademia dei Lincei in Rome and  Chair of the National Committee for the Selection of University Professors in Medical Microbiology.
He received research awards from the Juvenile Diabetes Research Foundation (JDRF, New York), the Network for Pancreatic Organ Donors (NPOD, Miami, FL), Post-Polio Health International (PHI, St. Louis, MO),  The Bran Institute (Tokyo, Japan), Wyeth-Lederle, Italy and other Italian and European Research Agencies.
For over 30 years he has been teaching and lecturing at the national and international levels. Opinion leader in medical microbiology has long experience with hospital-acquired infections, microbial drug resistance, transplants, community-acquired infections, pregnancy, childhood infections, virus-induced disorders, including type 1 diabetes and post-polio syndrome. As Clinical Microbiologist, has taken part to numerous Clinical Studies for Pharma Companies and CROs.
Scientific interests: association of virus infections with neurologic and endocrine disorders of unknown etiology, molecular diagnosis in microbiology, determinants and epidemiology of antimicrobial drug resistance.
Bibliometric data: Papers: 161, Citations: 4018, H-index: 36, Hc-index: 20
M.D., 1972 - University of Pisa Medical School, Italy
License to practice Medicine: Italy, 1976; Switzerland, 2002
Board Certification in Medical Microbiology: Italy, 1976; Switzerland, 2010
Post-Doctoral training in Experimental Medicine (1978-81), National Institutes of Health, Bethesda, MD, USA.


Dr. Norberto Guzman PHD.
Chief Scientific Officer at Princeton Biochemicals Inc.
Dr. Guzman is currently a member of the International Board of Advisory Directors at the International School of Medical Sciences, Panama City, Panama. 
He is also Chief Scientific Officer at Princeton Biochemicals Inc., Princeton, New Jersey, U.S.A.  Dr. Guzman expertise is primarily in protein biochemistry and immunochemistry.  He has developed immuno-analytical instrumentation and methodologies for the quantification, identification and characterization of proteins and peptides of relevance to the clinical laboratory, pharmaceutical


Electrophoresis, and the American Journal of Liquid Chromatography and Related Technologies.  Dr. Guzman is the founding editor of the Journal of Capillary Electrophoresis and Microchip Technology and one of the pioneers in this field.  He is also the founder of the international symposia series known as LACE (Latin-American Capillary Electrophoresis).  His main research interest is in the understanding of the function of certain proteins in inflammatory processes, and the finding of therapeutic agents, such as natural and synthetic proteins/peptides, aimed to alleviate chronic inflammatory diseases.  Dr. Guzman received a B.Sc. degree in biochemistry (clinical biochemistry) from a Joint Undergraduate Program of the University of Concepcion and the University of Chile, Santiago, Chile; a M.Sc. degree in biochemistry (cell and molecular biology) from the Medical College of Georgia, Augusta, Georgia, U.S.A.; and a Ph.D. degree in biochemistry (protein biochemistry) from a Joint Graduate Program of the University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School (formerly Rutgers Medical School) and Rutgers, The State University of New Jersey, New Brunswick, New Jersey, U.S.A.  Dr. Guzman has worked for the last 30 years in academic medical institutions, diagnostic and pharmaceutical companies, including Mount Sinai School of Medicine, Roche Diagnostic Systems, Hoffman-La Roche, and Johnson & Johnson.  He also has worked in a collagen food-nutraceutical industry.
DR. BOSHELL has held many important positions in the virology area, has held positions as Director in Colombia, including Secretary of Health, Scientific Researcher, Virology Group at National Institute of Health, Bogotá. Consultant of East Mediterranean Regional Office (EMRO) of the World Health Organization, he has contribute with more than 55 articles published in national and international scientific journals and 15 chapters in medical texts. More than 200 conferences in scientific congresses National and international.
· Sociedad Colombiana de Patología
· American Society of Tropical Medicine and Hygiene
· Asociación Colombiana de Infectología
· International AIDS Society
· The New York Academy of Sciences
1994. Harvard School of Public Health,
Department of Cancer Biology,
Essex Laboratory, Longwood
Campus, Boston, USA.
Epidemiología molecular del VIH1
1991. U.S. Department of Health and
Human Services, PHS,
Centers for Disease Control &
Prevention and PAHO.
Molecular Methods for the
Characterization of Polioviruses
Epidemiología molecular de los
1983. Viral and Rickettsial Disease
Laboratory, California State
Department of Health Services,
Berkeley, California, USA.
Virologia General
1982. Yale University School of
Medicine, Yale Arbovirus
Research Unit, New Haven,
Connecticut, USA
1980. Baylor College of Medicine,
Neurosensory Hospital,
Houston, Texas, USA.
Histoquimica de la Biopsia Muscular
Residencia en Patología,
Universidad Nacional de
Colombia, Hospitales de
San Juan de Dios, Misericordia
Y Materno Infantil, Bogotá
Especialista en Patología 1974-1977
1973. Universidad Nacional de Colombia,
Facultad de Medicina, Bogotá.
Doctor en Medicina y Cirugia. MD.
Yves Lacassie, MD, FACMG
Professor of Pediatrics
Yves Lacassie, M.D. is Professor of Pediatrics, Head of the Division of Clinical Genetics, Department of Pediatrics, Louisiana State University Health Sciences Center, and Director of Genetic Services, Children's Hospital of New Orleans. 
A graduate of the University of Chile, Dr. Lacassie had his formal training in Pediatrics and Genetics in Chile and at Johns Hopkins University under Dr. Victor A. McKusick. 
Dr. Lacassie has been the Head of the Division of Clinical Genetics, Department of Pediatrics, at LSUMC in New Orleans since 1986. 
He is board certified in Clinical Genetics and Founder Fellow of the American College of Medical Genetics.  
He belongs to several major scientific societies including the American Society of Human Genetics, European Society of Human Genetics, Asociación Latino-Americana   de Genética, and the Ibero-American Society of Human Genetics (President 1998-2000). 
His major interests are dysmorphology and cytogenetics disorders, the delineation of new syndromes, the nosology of genetic diseases, and the clinical use of dermatoglyphics.
 MD - 1967

University of Chile School of Medicine

Fellow, Pediatrics & Clinical Genetics, University of Chile, 1969-72
Fellow, Medical Genetics, Johns Hopkins University, 1973-75
Fellow, Pediatrics & Clinical Genetics, LSU &
Louisiana Birth Defects Center, New Orleans, LA, 1975-1976

Board Certification:
Clinical Genetics, 1990

Major Scientific/Professional Societies:
American Society of Human Genetics
European Society of Human Genetics
Ibero-American Society of Human Genetics (President, 1998-2000)
Latin-American Society of Genetics (ALAG)
Founder Fellow, American College of Medical Genetics
Latin-American Pediatrics Research Society 
Society for Craniofacial Genetics
American Dermatoglyphics Association

Research Interests
Dysmorphology, birth defects
Nosology of genetic diseases
Delineation of new syndromes
Cytogenetics & microdeletions
Ricardo Gomez, MD
Associate Professor of Clinical Pediatrics
Division of Endocrinology

Director, Pediatric Endocrinology Fellowship Program.

Dr. Ricardo Gomez He received his medical degree from Pontificia Universidad Javeriana in Bogota, Colombia, then completed his residency training at Universidad Colegio Mayor de Nuestra Senora del Rosario, also in Bogota, Colombia. He completed a fellowship in Pediatric Endocrinology at LSU Health New Orleans.        Specializes in Pediatric Endocrinology at Children’s Hospital.       He serves as an Associate Professor of Clinical Pediatrics in the Division of Endocrinology as well as the Director of Pediatric Endocrinology Fellowship Program at LSU Health New Orleans. 


Penny Scurto, MD. Outstanding Pediatric Resident Award. Year 2001-2002. LSUHSC. 

LWPES Awards Committee selection to attend ESPE Summer School 2001. 

Chief Resident. Pediatric University Hospital “Lorencita Villegas De Santos” University “Colegio Mayor de Nuestra Señora del Rosario. January, 1994 to January, 1995.

Second Place “Research Works” XIX Colombian Congress of Pediatrics“Gregorio Pinto Nuñez”.Barranquilla, Colombia.November 1 to 4, 1995.  

Best Resident in Pediatrics. First Semester, 1994.Board Certification Pediatrics 2002.

Clinical Interests

Diabetes control
Growth disorders
Esteban Schabelman MD, MBA, FACEP
Clinical Assistant Professor
Emergency Medicine
Regional Director of Emergency Medicine 
for West Baltimore.
Assistant Director of Population Health,
Department of Emergency Medicine.
University of Maryland; Baltimore.
Emergency Medicine Residency     
University of Maryland; Baltimore, MD                 
Resident in Emergency Medicine; 2009
Doctor of Medicine; University of Pennsylvania
School of Medicine Philadelphia, PA; 2006
Master in Business Administration; The Wharton School Philadelphia, PA; 2006 
Major: Healthcare Administration | Major: Business and Public Policy.
Bachelor of Arts, Cum Laude; Brandeis University Waltham, MA; 2001 Major: Biology | Major: Politics
Study Abroad; University of Edinburgh Edinburgh, Scotland; August 1999-January 2000


Board Certified, American Board of Emergency Medicine.

Fellow, American College of Emergency Physicians. 
Member, American Medical Association. 
Member, American Board of Physician Executives.
Esti Schabelman, M.D., M.B.A. is the Regional Director of Emergency Medicine for West Baltimore. He was previously the Chair of the Emergency Department at Bon Secours Hospital in inner city Baltimore.
He studied Healthcare Administration and Business & Public Policy at the Wharton school and has since consulted on multiple device product launches including ultrasound technologies, intravascular stents/ultrasounds, as well as new laboratory-based technologies.
Dr. Schabelman has become a recognized leader of Population Health initiatives in Maryland where he is invited to speak frequently on the topic of management plan implementation for reducing high ED-utilizer costs and visits; his implementation at Bon Secours has led to a 70% reduction in visits, admissions, opiate use, and costs for the highest ED users.
Dr. Schabelman has been through electronic medical record conversions at several hospitals, and led a remarkable go-live at Bon Secours where throughput and finances recovered after a paper to Epic transition after only one month.
Dr. Schabelman is an expert in throughput and efficiency; he has led multiple successful efforts to improve the flow of emergency departments. 
Dr. Schabelman's other credentials include the creation of an American-style ER in Panama,  where he was Chief of the ED as well as Chief and Founder of the first chest pain evaluation center in Panama. This involved creating and implementing all the protocols for a Joint Commission-compliant ED and chest pain/STEMI treatment center.
He also has extensive experience dealing with insurance companies, and created a billing system at a suburban American hospital that increased revenue by over $70k/month; he is well versed in telemedicine technology and legal issues as he has worked on telemedicine projects for the University of Maryland. He has authored multiple peer-reviewed publications regarding medical myths.
Dr. Schabelman is a fluent/native Spanish speaker.
Dr. Julio A Miranda, MD  FACP
Northampton, MA. & Pittsfield, Massachusetts.
With more than 25 years of experience in specialties that include: Critical Care MedicineInternal Medicine and Pulmonary Disease. He speaks English and Spanish.
Medical School
Universidad de Panamá, Panamá City1993.
Residency in Internal Medicine: Complejo Hospitalario CSS, Panamá,
República de Panamá
Residency in Internal Medicine: Cook County Hospital, Chicago USA
Chief Residents
Cook County Hospital, Chicago, Illinois. USA
Fellowship in Pulmonary & Critical Care: Dartmouth Hitchcock Medical Center Lebanon, New Hampshire & Veterans Hospital of White River Junction Vermont. USA
Interventional Bronchoscopy.  Beth Israel Deaconess Medical Center
Harvard University, Boston, MA, USA
Board certified in Internal Medicine, Board certified in Critical Care Medicine and Board certified in Pulmonary Disease.
MA State Medical License Active.
 American College of Physicians
American Thoracic Society
American Society of Bronchology
American College of Chest Physicians
Society of Critical Care Medicine
New Hampshire Medical Society